ARDS (Moderate or Severe)

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Lungpacer Medical
Lungpacer MedicalBC - Vancouver
1 program
Phrenic Nerve StimulationN/A1 trial
Active Trials
NCT06832306RecruitingEst. Dec 2026

Trial Timeline

Clinical trial activity over time

2025
2026
Lungpacer MedicalPhrenic Nerve Stimulation

Clinical Trials (1)

NCT06832306Lungpacer MedicalPhrenic Nerve Stimulation

STimulation to Activate RespIration

Start: May 2025Est. completion: Dec 2026
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space